Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
87.87 EUR | -0.80% | -3.23% | -2.11% |
May. 28 | EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project | RE |
May. 27 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.11% | 120B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.21% | 238B | |
+7.06% | 204B | |
-6.18% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Dupixent Supplemental Application for Priority Review